Aspira Pathlab & Diagnostics informs about disclosure

09 Apr 2024 Evaluate
Aspira Pathlab & Diagnostics has confirmed that Aspira Pathlab & Diagnostics does not qualify for Large Corporate (LC) in accordance with the criteria provided by SEBI vide Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. Accordingly, Annual Disclosure as mentioned in Annexure B2 of the said circular for the financial year 2023-2024 is not applicable to the Company.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

59.66 -2.14 (-3.46%)
02-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 6933.65
Max Healthcare Inst 958.45
Narayana Hrudayalay 1763.85
Aster DM Healthcare 556.95
Global Health 1140.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×